DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Contribución de congreso (ConferenceOutput)
Brain neovascularization mediated by p53 signaling pathway determines functional recovery after intracerebral hemorrhage
Trabajo presentado en el European Stroke Organisation and the World Stroke Organization 2020 Virtual Conference (ESO-WSO), celebrado online del 7 al 9 de noviembre de 2020, Background And Aims: Brain neovascularization has been associated with good prognosis of
intracerebral hemorrhage (ICH) patients. We previously showed that the human Tp53 Arg72Pro
SNP modulates brain endothelial cells survival after ICH, which is essential for the secretion
of growth factors and cytokines (i.e. VEGF) that mediate the mobilization of endothelial
progenitor cells (EPCs) from the bone marrow to the peripheral blood. EPCs promote brain vascular
repair after ICH. Then, pro-apoptotic p53 would be a negative regulator of EPC mobilization, thus
affecting the functional outcome after ICH. Since p53 is accumulated in the brain after ICH, we speculate that p53 destabilization not only will promote cell survival, but also vascular recovery and
brain repair.
Methods: p53 KO mice were subjected to an experimental model of ICH in vivo by injecting bacterial
collagenase into the basal ganglia. Proliferative markers and perfusion status of newly-formed brain
blood vessels in the brain was also analyzed by Evans blue injection.
Results: We observed that p53 loss reduced lesion volume and increased levels of circulating EPCs. As
a consequence, an improved vascular response was achieved in p53 KO mice, in comparison with those
expressing an active p53 protein.
Conclusions: Our results point out the impact of the p53 signaling pathway in the balance between
brain damage and repair, which might condition functional recovery after ICH., Funded by ISCIII(PI18/00265; RD16/0019/0018), FEDER, EU Horizon 2020 Research and Innovation Programme (Grant
Agreement 686009), Junta de Castilla y Leon (IES007P17; Escalera de Excelencia CLU-2017-03
Cofinanciado por el P.O. FEDER de Castilla y Leon 14–20); RedHYPOX (SAF2017-90794-REDT)